journal article·2026-05Open access

Bifunctional Artificial Enzymes‐Loaded Microgels With LOX‐ and CAT‐Like Activities for Metabolic Reprogramming and Scarless Wound Repair

Yongyuan Kang, Pai Peng, Liang Song, Qiaoxuan Wang, Zilong Zhong, Dongchao Qiu, Yunfan Liu, Kefei Zhao, Xiaofei Dong, Changyou Gao

Advanced Science· Volume 13· Issue 27

Abstract

ABSTRACT Lactate plays a central role in regulating wound metabolism and has been implicated in fibrosis through mechanisms such as histone lactylation and endothelial‐to‐mesenchymal transition. However, strategies to modulate lactate‐driven metabolic imbalance and oxidative stress remain limited. Herein, a metabolism‐regulating and inflammation‐modulatory artificial enzyme, Metazyme, was developed, which exhibited dual lactate oxidase (LOX)‐like and catalase (CAT)‐like activities to oxidize lactate and decompose hydrogen peroxide (H 2 O 2 ), enabling efficient oxygen recycling. Embedding Metazyme into a rod‐shaped microgel matrix yielded MetaRgel, a localized and sustained catalytic platform for wound microenvironment modulation. The MetaRgel reduced lactate and reactive oxygen species (ROS) levels, relieved hypoxia, and downregulated glycolysis‐related enzymes such as pyruvate kinase (PKM2) and pyruvate dehydrogenase kinase isoform 1 (PDK1) in vitro and thereby suppressed the pro‐inflammatory cytokine interleukin‐6 (IL‐6) and the fibrotic mediator transforming growth factor‐β1 (TGF‐β1). In a rat full‐thickness wound model in vivo, the MetaRgel significantly accelerated healing, enhanced granulation and collagen organization, and notably reduced glycolytic enzyme activity as well as the fibrotic marker α‐smooth muscle actin (α‐SMA) and hypoxia‐inducible factor 1α (HIF‐1α). The targeting of lactate‐centered metabolic dysregulation with cascade artificial enzymes offers a promising approach to interrupt inflammation‐metabolism‐fibrosis crosstalk and promote scarless skin regeneration.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Wound Healing and Treatments · Hydrogels: synthesis, properties, applications · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Zhejiang Key Laboratory of Advanced Organic Materials and Technologies MOE Key Laboratory of Macromolecular Synthesis and Functionalization Department of Polymer Science and Engineering Zhejiang University Hangzhou China

Zhejiang Engineering Research Center For Interface Technology of Medical Polymers and Devices Shaoxing Key Laboratory of Healthcare Materials and Application Technology and Center for Healthcare Materials Shaoxing Institute Zhejiang University Shaoxing China

Dr. Li Dak Sum & Yip Yio Chin Center for Stem Cell and Regenerative Medicine Zhejiang University Hangzhou China

Funding

National Key Research and Development Program of China · Higher Education Discipline Innovation Project · National Natural Science Foundation of China

References (56)

Show source-provided references
1. 10.1038/s41586‐019‐1678‐110.1038/s41586‐019‐1678‐1 ↗
2. 10.1172/jci.insight.13894910.1172/jci.insight.138949 ↗
3. 10.1016/j.immuni.2025.02.00810.1016/j.immuni.2025.02.008 ↗
4. 10.1016/j.burns.2021.03.00310.1016/j.burns.2021.03.003 ↗
5. 10.1111/j.1464‐5491.2010.03123.x10.1111/j.1464‐5491.2010.03123.x ↗
6. 10.1038/s41392‐022‐01151‐310.1038/s41392‐022‐01151‐3 ↗
7. 10.1007/s10456‐012‐9282‐010.1007/s10456‐012‐9282‐0 ↗
8. 10.1002/advs.20240618410.1002/advs.202406184 ↗
9. 10.1038/s41598‐020‐65193‐910.1038/s41598‐020‐65193‐9 ↗
10. 10.1111/exd.1412110.1111/exd.14121 ↗
11. 10.1016/j.ebiom.2024.10550210.1016/j.ebiom.2024.105502 ↗
12. 10.1186/s12967‐025‐06748‐010.1186/s12967‐025‐06748‐0 ↗
13. 10.3892/mmr.2025.1365510.3892/mmr.2025.13655 ↗
14. 10.1016/j.bioactmat.2021.10.01310.1016/j.bioactmat.2021.10.013 ↗
15. 10.1016/j.biomaterials.2026.12400510.1016/j.biomaterials.2026.124005 ↗
16. 10.1002/advs.20220690010.1002/advs.202206900 ↗
17. 10.1039/D3NR05952A10.1039/D3NR05952A ↗
18. 10.1186/s12951-022-01762-610.1186/s12951-022-01762-6 ↗
19. 10.1016/j.matt.2023.01.00110.1016/j.matt.2023.01.001 ↗
20. 10.1002/adfm.20241367810.1002/adfm.202413678 ↗
21. 10.1039/D2TA09501G10.1039/D2TA09501G ↗
22. 10.1021/jacs.3c0200510.1021/jacs.3c02005 ↗
23. 10.1002/anie.20211606810.1002/anie.202116068 ↗
24. 10.1021/acsami.8b0057310.1021/acsami.8b00573 ↗
25. 10.1007/s40820‐025‐01657‐910.1007/s40820‐025‐01657‐9 ↗
26. 10.1002/smll.20230972710.1002/smll.202309727 ↗
27. 10.1021/jacs.9b1080910.1021/jacs.9b10809 ↗
28. 10.1038/s41598‐018‐26997‐y10.1038/s41598‐018‐26997‐y ↗
29. 10.1038/s41598‐018‐26370‐z10.1038/s41598‐018‐26370‐z ↗
30. 10.1039/D2NR06096E10.1039/D2NR06096E ↗
31. 10.1039/C3RA41132J10.1039/C3RA41132J ↗
32. 10.1016/j.jmmm.2017.06.01410.1016/j.jmmm.2017.06.014 ↗
33. 10.1038/s41467‐024‐51022‐410.1038/s41467‐024‐51022‐4 ↗
34. 10.1016/j.apcatb.2024.12469910.1016/j.apcatb.2024.124699 ↗
35. 10.1002/advs.20251151310.1002/advs.202511513 ↗
36. 10.1002/adma.20210919410.1002/adma.202109194 ↗
37. 10.1021/acs.nanolett.0c0137110.1021/acs.nanolett.0c01371 ↗
38. 10.1016/j.biopha.2024.11708410.1016/j.biopha.2024.117084 ↗
39. 10.1186/s12964‐024‐01624‐810.1186/s12964‐024‐01624‐8 ↗
40. 10.3390/cancers1710169110.3390/cancers17101691 ↗
41. 10.1016/j.immuni.2013.10.02210.1016/j.immuni.2013.10.022 ↗
42. 10.1016/j.ijbiomac.2023.12380910.1016/j.ijbiomac.2023.123809 ↗
43. 10.1039/D1MD00045D10.1039/D1MD00045D ↗
44. 10.1126/sciadv.abo098710.1126/sciadv.abo0987 ↗
45. 10.1186/s12943‐015‐0490‐210.1186/s12943‐015‐0490‐2 ↗
46. 10.3389/fimmu.2019.0291910.3389/fimmu.2019.02919 ↗
47. 10.3389/fphys.2025.159663610.3389/fphys.2025.1596636 ↗
48. 10.1096/fj.202302063RR10.1096/fj.202302063RR ↗
49. 10.1016/j.jmst.2024.04.04610.1016/j.jmst.2024.04.046 ↗
50. 10.1038/s41598‐022‐16376‐z10.1038/s41598‐022‐16376‐z ↗
51. 10.1002/mco2.7038110.1002/mco2.70381 ↗
52. 10.1016/j.jallcom.2015.02.01310.1016/j.jallcom.2015.02.013 ↗
53. 10.1038/s41467‐025‐62063‐810.1038/s41467‐025‐62063‐8 ↗
54. 10.1002/adma.20221104110.1002/adma.202211041 ↗
55. 10.1021/acsami.4c0178310.1021/acsami.4c01783 ↗
56. 10.1007/978‐1‐61779‐867‐2_2010.1007/978‐1‐61779‐867‐2_20 ↗